Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
3F, No.95, Guangfu North Road , Songshan District, Taipei, 105, TW
It is the second FDA-approved indication for Aqneursa, following Niemann-Pick disease type C.
By: Patrick Lavery
The CDMO is adding new property, aseptic fill-finish lines, packaging capacity, and analytical capabilities at its Caponago site near Milan.
By: Charlie Sternberg
Highly potent compounds are reshaping CDMO expectations, from early risk assessment to closed, automated containment facilities.
$200M investment boosts sterile injectable drug production capacity in Albuquerque.
The program the agreement centers around is expected to generate commercial revenues in 2028.
The agreement covers commercial manufacturing and supply of 20+ sterile injectables, biologics and topical products across key global markets.
The $45 million investment expands domestic sterile manufacturing capacity for pharma and biotech clients.
August Bioservices’ Ryan Downey discusses fill-finish capacity, Annex 1 readiness, technical expertise and the infrastructure needed to move injectable programs toward commercial launch.
Released By August Bioservices
How integrating risk-based thinking into everyday quality processes can strengthen compliance, decision-making and product oversight.
By: Sadie Harrison
Proprietary candidate NB4168 has been developed for treatment of ataxia telangiectasia.
Funding will support preclinical development of PBS293-exatecan for colorectal cancer and other solid tumors.
The new Palmetto Research Park facility will produce life-saving plasma medicines and trauma care products for U.S. supply needs.
Supporting the Next Wave of Injectable Therapies
Released By Jones Healthcare Group
Vetter’s Carsten Press discusses the strategy behind the company’s global investments and what they mean for injectable drug customers.
Released By Vetter Pharma International
How sponsors can navigate sterility, microbiology, E&L, and regulatory expectations as combination products become more complex.
Released By Nelson Laboratories, LLC
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
